---
schema_version: "secwatch.filing_event.v1"
accession: "0001091818-26-000124"
form_type: "8-K"
ticker: "BFNH"
cik: "0001310488"
company_name: "BIOFORCE NANOSCIENCES HOLDINGS, INC."
filed_at: "2026-08-14T19:23:23+00:00"
generated_at: "2026-08-14T19:24:05.276939+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# BioForce NanoSciences appoints interim CEO, adds director and advisory board members

## Summary
- Richard Kaiser appointed interim CEO on June 17, 2026; he remains CFO, Secretary, and Director.
- Scott Mager appointed General Counsel on May 19, 2026, and Director on June 15, 2026.
- Advisory Board established May 19, 2026; Stuart Yarbrough and Edward Mathias appointed for 3-year terms ending May 19, 2029.
- Yarbrough is CPA with 20+ years at Ernst & Young and BDO; Mathias is senior advisor to Carlyle Group.

## SEC filing metadata
- accession: 0001091818-26-000124
- form_type: 8-K
- ticker: BFNH
- cik: 0001310488
- company_name: BIOFORCE NANOSCIENCES HOLDINGS, INC.
- filed_at: 2026-08-14T19:23:23+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1310488/000109181826000124/0001091818-26-000124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1310488/000109181826000124/bfnh-08142026_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001091818-26-000124
- JSON: https://secwatch.observer/filing/0001091818-26-000124.json
- Plain text: https://secwatch.observer/filing/0001091818-26-000124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.